SIHUAN PHARM (00460.HK) -0.170 (-2.640%) Short selling $6.24M; Ratio 2.004% has delivered experimental anti-Ebola drugs JK-05 to Africa. The drugs will be provided to the Chinese aid workers and used in the tentative experiment in Africa for combating the epidemic, reported by Reuters quoting from the CEO Che Fengsheng.
BASETROPHY GP (08460.HK) Expects Jan-Aug Results to Swing to Loss BASETROPHY GP (08460.HK) -0.013 (-8.280%) issued a profit warning. The group is expected to record a loss for the eight months ended 31 August 2017 as compared with a net profit for the same period of 2016, mainly due to the decrease in revenue recognised by the group and increase of listing expense
Comments
Post a Comment